Pattern hair loss is a medical condition.
Shouldn’t we treat it like one?
Pattern hair loss (PHL) affects more people than almost every other chronic dermatologic condition.
more than cosmetic
PHL isn’t simply a cosmetic inconvenience.
Beyond what’s in the mirror, it impacts confidence, relationships, and mental health, resulting in low self-esteem and social withdrawal.
Yet PHL is often treated as a cosmetic problem rather than a medical one.
We believe hair loss deserves the same medical attention as any other chronic dermatologic condition. That’s why we’re working to redefine the way it’s understood—and treated.
PHL Quick Facts
Pattern hair loss affects 50 million men and 30 million women in the US alone.1
PHL demonstrates a lifetime prevalence of nearly 50%
By age 50,
90%
of men with PHL experience some emotional distress.2
88%
of women with PHL felt the condition negatively affected their day-to-day lives.2
93%
of people want treatment for pattern hair loss.3
9 out of 10
people with PHL are not satisfied with current treatment options.3
clinical trials underway
Now enrolling females
with pattern hair loss
We are currently enrolling female participants in the first Phase 2/3 national clinical trial for women with pattern hair loss to evaluate our lead product candidate, VDPHL01, the potential first-ever, extended-release, oral minoxidil for hair growth.
For more information and to find a study site:

References:
- MedlinePlus. Androgenetic alopecia. Updated July 27, 2023. Accessed April 8, 2026. https://medlineplus.gov/genetics/condition/androgenetic-alopecia
- Aukerman EL, Jafferany M. The psychological consequences of androgenetic alopecia: A systematic review. J Cosmet Dermatol. 2023;22(1):89-95. doi:10.1111/jocd.14983
- Data on file. Veradermics, Inc.